Clinical and Experimental Pediatrics

Search

Search

Close


Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-11.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 93

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 94

All issues > Volume 47(8); 2004

Medical Lecture Course
Korean J Pediatr. 2004;47(8):815-820. Published online August 15, 2004.
Impact of Host Genetics on Susceptibility and Outcome of Viral Infections
Eun Hwa EH Choi1
1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
Correspondence Eun Hwa EH Choi ,Email: eunchoi@snu.ac.kr
Abstract
The generation of a draft sequence of the human genome has lead to an opportunity to characterize human diversity, including the differences in host response to numerous pathogens. Host responses upon exposure to a pathogen can determine the wide spectrum of illness from subclinical or mild to severe diseases. Host factors, particularly genetic backgrounds, influence the pathogenesis of infectious diseases. Both epidemiological and experimental studies have suggested that there is a genetic component that contributes to susceptibility and possibly outcomes of infectious diseases caused by multiple different pathogens. Studies in identifying the relationship between infections and polymorphisms have focused on human leukocyte antigen, cytokines, other immune response, or pathogen receptor genes. Genetic studies in infectious diseases have been challenging because of the complex interaction between the human host and pathogens, which also have their own genome. However, the new tools of bioinformatics and high throughput genotyping platforms had offered the better prospects for dissecting the genetics of both susceptibility and outcome. This review summarized recent knowledge in understanding the role of host genetics on three major viral infections; human immunodeficiency virus, hepatitis B virus, and respiratory syncytial virus. Rapid advances in the identification of susceptibility (or resistance) genes will provide new insights into therapeutic strategies including pharmacological intervention and vaccine development.

Keywords :Genetic variation, Single nucleotide polymorphisms, Human immunodeficiency virus, Hepatitis B virus, Respiratory syncytial virus

Go to Top